logo

FDA Calendar

Share
Company Name scPharmaceuticals Inc.
Drug Name FUROSCIX (Resubmitted NDA)
Event Name FDA decision on FUROSCIX or the treatment of worsening heart failure due to congestion
Event Date 12/30/2020
Outcome Date
Outcome
Drug Status FUROSCIX was refused approval by the FDA in June 2018,
Rival Drugs
Market Potential
Other Approvals
News
Return to FDA Calendar